17-47284514-G-T

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PS3PM3_SupportingPP1PP3PM2_SupportingPP4_Moderate

This summary comes from the ClinGen Evidence Repository: The NM_000212.2(ITGB3):c.433G>T (p.Asp145Tyr) is a missense variant that is expressed normally on the platelet surface, but lacks the function of ligand binding (PMID:2392682, PMID:15583747). It has been reported in 2 siblings with variant GT, in the homozygous state (PMIDs: 2428841, 2392682, 7520434) and a compound heterozygote (with Met150Val;PMID:15583747). It is absent from population databases and has a REVEL score of 0.972 (threshold: >0.7). In summary, based on the available evidence at this time, the variant is classified as Pathogenic. GT-specific criteria applied: PS3, PM2_Supporting, PP1, PP3, PP4_Moderate, PM3_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA123226/MONDO:0010119/011

Frequency

Genomes: not found (cov: 32)

Consequence

ITGB3
NM_000212.3 missense

Scores

16
1
1

Clinical Significance

Pathogenic reviewed by expert panel P:2

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
ITGB3 (HGNC:6156): (integrin subunit beta 3) The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PS3
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ITGB3NM_000212.3 linkuse as main transcriptc.433G>T p.Asp145Tyr missense_variant 4/15 ENST00000559488.7 NP_000203.2 P05106-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ITGB3ENST00000559488.7 linkuse as main transcriptc.433G>T p.Asp145Tyr missense_variant 4/151 NM_000212.3 ENSP00000452786.2 P05106-1
ITGB3ENST00000571680.1 linkuse as main transcriptc.433G>T p.Asp145Tyr missense_variant 4/91 ENSP00000461626.1 I3L4X8
ENSG00000259753ENST00000560629.1 linkuse as main transcriptn.397G>T non_coding_transcript_exon_variant 4/182 ENSP00000456711.2 H3BM21
ITGB3ENST00000696963.1 linkuse as main transcriptc.433G>T p.Asp145Tyr missense_variant 4/14 ENSP00000513002.1 P05106-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000882
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Glanzmann thrombasthenia Pathogenic:1
Pathogenic, reviewed by expert panelcurationClinGen Platelet Disorders Variant Curation Expert Panel, ClinGenSep 06, 2020The NM_000212.2(ITGB3):c.433G>T (p.Asp145Tyr) is a missense variant that is expressed normally on the platelet surface, but lacks the function of ligand binding (PMID: 2392682, PMID:15583747). It has been reported in 2 siblings with variant GT, in the homozygous state (PMIDs: 2428841, 2392682, 7520434) and a compound heterozygote (with Met150Val;PMID: 15583747). It is absent from population databases and has a REVEL score of 0.972 (threshold: >0.7). In summary, based on the available evidence at this time, the variant is classified as Pathogenic. GT-specific criteria applied: PS3, PM2_Supporting, PP1, PP3, PP4_Moderate, PM3_Supporting. -
Glanzmann thrombasthenia 2 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 24, 1990- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.98
D;.
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.0
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D;D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Pathogenic
3.9
H;.
PrimateAI
Pathogenic
0.79
T
PROVEAN
Pathogenic
-8.5
D;.
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
1.0
MutPred
0.99
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);
MVP
0.98
MPC
1.4
ClinPred
1.0
D
GERP RS
5.8
Varity_R
0.99
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121918445; hg19: chr17-45361880; API